Barclays’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.4M Buy
219,807
+49,942
+29% +$3.73M ﹤0.01% 899
2025
Q1
$10.8M Buy
169,865
+47,730
+39% +$3.03M ﹤0.01% 973
2024
Q4
$9.54M Buy
122,135
+19,602
+19% +$1.53M ﹤0.01% 1156
2024
Q3
$8.24M Buy
102,533
+67,470
+192% +$5.42M ﹤0.01% 1150
2024
Q2
$2.9M Sell
35,063
-68,802
-66% -$5.69M ﹤0.01% 1458
2024
Q1
$8.87M Sell
103,865
-15,034
-13% -$1.28M ﹤0.01% 1092
2023
Q4
$10.2M Buy
118,899
+81,303
+216% +$6.95M ﹤0.01% 1048
2023
Q3
$3.37M Sell
37,596
-6,059
-14% -$543K ﹤0.01% 1366
2023
Q2
$3.72M Buy
43,655
+5,606
+15% +$477K ﹤0.01% 1385
2023
Q1
$3.15M Buy
38,049
+15,572
+69% +$1.29M ﹤0.01% 1358
2022
Q4
$1.77M Buy
22,477
+16,427
+272% +$1.29M ﹤0.01% 1714
2022
Q3
$447K Buy
6,050
+1,614
+36% +$119K ﹤0.01% 2657
2022
Q2
$289K Sell
4,436
-7,822
-64% -$510K ﹤0.01% 2929
2022
Q1
$776K Sell
12,258
-62,235
-84% -$3.94M ﹤0.01% 2493
2021
Q4
$3.95M Buy
74,493
+17,293
+30% +$917K ﹤0.01% 1383
2021
Q3
$4.04M Buy
57,200
+19,084
+50% +$1.35M ﹤0.01% 1365
2021
Q2
$2.54M Buy
38,116
+12,717
+50% +$847K ﹤0.01% 1583
2021
Q1
$2.82M Buy
25,399
+23,993
+1,706% +$2.66M ﹤0.01% 1617
2020
Q4
$167K Sell
1,406
-385
-21% -$45.7K ﹤0.01% 2777
2020
Q3
$157K Sell
1,791
-16,239
-90% -$1.42M ﹤0.01% 2849
2020
Q2
$1.61M Sell
18,030
-1,335
-7% -$120K ﹤0.01% 1619
2020
Q1
$1.93M Sell
19,365
-40,045
-67% -$3.99M ﹤0.01% 1355
2019
Q4
$6.83M Buy
59,410
+23,880
+67% +$2.74M ﹤0.01% 1036
2019
Q3
$4.48M Sell
35,530
-5,238
-13% -$661K ﹤0.01% 1163
2019
Q2
$4.91M Sell
40,768
-4,702
-10% -$566K ﹤0.01% 1109
2019
Q1
$3.98M Buy
45,470
+31,421
+224% +$2.75M ﹤0.01% 1109
2018
Q4
$1.41M Sell
14,049
-28,064
-67% -$2.81M ﹤0.01% 1595
2018
Q3
$4.83M Sell
42,113
-3,505
-8% -$402K ﹤0.01% 1098
2018
Q2
$4.09M Buy
45,618
+28,453
+166% +$2.55M ﹤0.01% 1064
2018
Q1
$1.26M Buy
17,165
+5,729
+50% +$419K ﹤0.01% 1647
2017
Q4
$664K Buy
11,436
+8,294
+264% +$482K ﹤0.01% 1895
2017
Q3
$141K Sell
3,142
-10,187
-76% -$457K ﹤0.01% 2551
2017
Q2
$527K Buy
13,329
+11,927
+851% +$472K ﹤0.01% 1886
2017
Q1
$57K Buy
1,402
+255
+22% +$10.4K ﹤0.01% 3053
2016
Q4
$46K Sell
1,147
-1,047
-48% -$42K ﹤0.01% 2866
2016
Q3
$79K Sell
2,194
-2,162
-50% -$77.8K ﹤0.01% 2527
2016
Q2
$126K Sell
4,356
-36,341
-89% -$1.05M ﹤0.01% 2261
2016
Q1
$1.38M Buy
40,697
+33,714
+483% +$1.15M ﹤0.01% 1255
2015
Q4
$224K Buy
6,983
+6,367
+1,034% +$204K ﹤0.01% 1992
2015
Q3
$19K Sell
616
-376
-38% -$11.6K ﹤0.01% 2855
2015
Q2
$40K Sell
992
-641
-39% -$25.8K ﹤0.01% 2696
2015
Q1
$71K Sell
1,633
-1,331
-45% -$57.9K ﹤0.01% 2616
2014
Q4
$109K Buy
2,964
+1,076
+57% +$39.6K ﹤0.01% 2660
2014
Q3
$64K Buy
1,888
+963
+104% +$32.6K ﹤0.01% 2849
2014
Q2
$32K Sell
925
-1,263
-58% -$43.7K ﹤0.01% 3231
2014
Q1
$70K Sell
2,188
-17,737
-89% -$567K ﹤0.01% 2970
2013
Q4
$836K Sell
19,925
-28,455
-59% -$1.19M ﹤0.01% 1865
2013
Q3
$1.89M Sell
48,380
-23,939
-33% -$934K ﹤0.01% 1321
2013
Q2
$2.99M Buy
+72,319
New +$2.99M ﹤0.01% 1078